The Colorado Fund is a venture capital fund seeking to invest in seed and early stage businesses in Colorado.
Business Model: B2B
Revenue: $10.5M
Employees: 2-10
Address: 831 Pearl St
City: Boulder
State: CO
Zip: 80302
Country: US
The Colorado Fund is a venture capital fund seeking to invest in seed and early stage businesses in Colorado. The fund will focus its investments in Life Sciences (including biotechnology, clean technology, and medical devices), information technology (including software and Internet companies) and retail. They encourage all qualified businesses in rural areas who are seeking capital to submit a business plan, regardless of the industry you are in.
Contact Phone:
+13033812638
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2015 | TriSalus Life Sciences | Series C | 0 |
4/2016 | Covalent Data | Series A | 0 |
11/2013 | Covalent Data | Series A | 0 |
5/2015 | Documoto | Series B | 9M |
12/2008 | Nutrinsic | Debt Financing | 675k |
9/2010 | Kapost | Series A | 1.1M |
7/2013 | Kapost | Venture Round | 5.6M |
8/2014 | Nutrinsic | Series C | 12.7M |
9/2010 | Documoto | Seed Round | 1.2M |
9/2010 | Documoto | Venture Round | 1.2M |
12/2013 | Nutrinsic | Series B | 12.7M |
7/2011 | Cool Energy | Venture Round | 1M |
5/2015 | Kapost | Venture Round | 0 |
7/2008 | Sierra Neuropharmaceuticals Inc. | Series A | 0 |
11/2011 | Mosaic Biosciences | Series A | 1M |
11/2007 | LogRhythm | Series A | 3.3M |
9/2011 | FullContact | Seed Round | 1.9M |
1/2012 | Kapost | Venture Round | 1.5M |
8/2005 | Taligen Therapeutics | Series A | 3.8M |
1/2012 | Mosoro | Series A | 0 |
8/2013 | FitBionic | Unattributed | 2.2M |
2/2007 | Envysion | Series B | 0 |
8/2010 | Taligen Therapeutics | Series B | 10M |
11/2011 | TriSalus Life Sciences | Series A | 6.1M |
8/2008 | Envysion | Series C | 0 |
1/2012 | Qualvu | Series B | 1.9M |
7/2013 | Documoto | Series A | 3M |
1/2008 | Taligen Therapeutics | Series B | 65M |
4/2009 | LogRhythm | Series B | 3.1M |
4/2011 | Sovrn | Venture Round | 11M |
4/2015 | Nutrinsic | Venture Round | 1.6M |
8/2007 | Nutrinsic | Series A | 1M |
11/2013 | Collective IP | Series A | 2.5M |
11/2013 | TriSalus Life Sciences | Series B | 0 |
7/2012 | FullContact | Series A | 7M |
4/2016 | Covalent Data | Series A | 0 |
12/2015 | TriSalus Life Sciences | Series C | 0 |
5/2015 | Kapost | Venture Round | 0 |
5/2015 | Documoto | Series B | 0 |
4/2015 | Nutrinsic | Venture Round | 0 |
8/2014 | Nutrinsic | Series C | 0 |
12/2013 | Nutrinsic | Series B | 0 |
11/2013 | Collective IP | Series A | 0 |
11/2013 | Covalent Data | Series A | 0 |
11/2013 | TriSalus Life Sciences | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|